{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:51:49Z","timestamp":1761709909735,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s10840-021-01073-0","type":"journal-article","created":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T11:07:10Z","timestamp":1637838430000},"page":"497-509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9993-1846","authenticated-orcid":false,"given":"Nicolas","family":"Dognin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwan","family":"Salaun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Champagne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Domain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"O\u2019Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Philippon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Faroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Beaudoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Bernier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Rod\u00e9s-Cabau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Champagne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"issue":"2","key":"1073_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GYH Lip","year":"2010","unstructured":"Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest. 2010;137(2):263\u201372. https:\/\/doi.org\/10.1378\/chest.09-1584.","journal-title":"Chest"},{"key":"1073_CR2","doi-asserted-by":"publisher","unstructured":"Takashima N, Arima H, Kita Y, Fujii T, Miyamatsu N, Komori M, \u2026 Nozaki K. Incidence, management and short-term outcome of stroke in a general population of 1.4 million Japanese- Shiga Stroke Registry. Circ J. 2017; 81 (11):1636\u20131646. https:\/\/doi.org\/10.1253\/circj.CJ-17-0177","DOI":"10.1253\/circj.CJ-17-0177"},{"key":"1073_CR3","doi-asserted-by":"publisher","unstructured":"Lip GYH, Collet JP, de Caterina R, Fauchier L, Lane DA, Larsen TB, \u2026 Scott-Millar R. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulaci\u00f3n Card\u00edaca y Electrofisiolog\u00eda (SOLEACE). EP Europace. 2017;19(11):1757\u20131758. https:\/\/doi.org\/10.1093\/europace\/eux240","DOI":"10.1093\/europace\/eux240"},{"key":"1073_CR4","doi-asserted-by":"crossref","unstructured":"Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, \u2026 Sick P. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. 2009;374:9.","DOI":"10.1016\/S0140-6736(09)61343-X"},{"key":"1073_CR5","doi-asserted-by":"publisher","unstructured":"Holmes DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, \u2026 Reddy VY. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy. J Am Coll Cardiol. 2014;64(1):1\u201312. https:\/\/doi.org\/10.1016\/j.jacc.2014.04.029","DOI":"10.1016\/j.jacc.2014.04.029"},{"key":"1073_CR6","doi-asserted-by":"publisher","unstructured":"Reddy VY, M\u00f6bius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, \u2026 Sievert H. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation. J Am Coll Cardiol. 2013;61(25):2551\u20132556. https:\/\/doi.org\/10.1016\/j.jacc.2013.03.035","DOI":"10.1016\/j.jacc.2013.03.035"},{"key":"1073_CR7","doi-asserted-by":"publisher","unstructured":"Boersma LVA, Schmidt B, Betts TR, Sievert H, Tamburino C, Teiger E, \u2026 Bergmann MW. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J. 2016;37(31):2465\u20132474. https:\/\/doi.org\/10.1093\/eurheartj\/ehv730","DOI":"10.1093\/eurheartj\/ehv730"},{"key":"1073_CR8","doi-asserted-by":"publisher","unstructured":"January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, \u2026 Yancy CW. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2019;74(1):104\u2013132. https:\/\/doi.org\/10.1016\/j.jacc.2019.01.011","DOI":"10.1016\/j.jacc.2019.01.011"},{"key":"1073_CR9","doi-asserted-by":"publisher","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, \u2026 Zakirov NU. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2020;ehaa612. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612","DOI":"10.1093\/eurheartj\/ehaa612"},{"key":"1073_CR10","doi-asserted-by":"publisher","unstructured":"Shokr M, Adegbala O, Elmoghrabi A, Saleh M, Ajam M, Ali A, \u2026 Afonso L. Impact of chronic thrombocytopenia on outcomes after transcatheter valvular intervention and cardiac devices implantation (from a national inpatient sample). Am J Cardiol. 2019;124(10):1601\u20131607. https:\/\/doi.org\/10.1016\/j.amjcard.2019.08.012","DOI":"10.1016\/j.amjcard.2019.08.012"},{"key":"1073_CR11","doi-asserted-by":"publisher","unstructured":"Pastori D, Antonucci E, Violi F, Palareti G, Pignatelli P, Testa S, Liberato NL. Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry. Journal of the American Heart Association. 2019;8(21).https:\/\/doi.org\/10.1161\/JAHA.119.012596","DOI":"10.1161\/JAHA.119.012596"},{"issue":"3","key":"1073_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/FJC.0000000000000607","volume":"72","author":"A Janion-Sadowska","year":"2018","unstructured":"Janion-Sadowska A, Papuga-Szela E, \u0141ukaszuk R, Chrapek M, Undas A. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and thrombocytopenia. J Cardiovasc Pharmacol. 2018;72(3):153\u201360. https:\/\/doi.org\/10.1097\/FJC.0000000000000607.","journal-title":"J Cardiovasc Pharmacol"},{"key":"1073_CR13","doi-asserted-by":"publisher","unstructured":"Wang C-L, Wu VC-C, Lee C-H, Kuo C-F, Chen Y-L, Chu P-H, \u2026 Chang S-H. Effectiveness and safety of non-vitamin-K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with thrombocytopenia. J Thromb Thrombolysis. 2019;47(4): 512\u2013519. https:\/\/doi.org\/10.1007\/s11239-018-1792-1","DOI":"10.1007\/s11239-018-1792-1"},{"key":"1073_CR14","doi-asserted-by":"publisher","unstructured":"Horv\u00e1th-Puh\u00f3 E, Suttorp MM, Frederiksen H, Hoekstra T, Dekkers OM, Pedersen L, \u2026 S\u00f8rensen HT. Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma. Clin Epidemiol. 2018;10: 1371\u20131380. https:\/\/doi.org\/10.2147\/CLEP.S172306","DOI":"10.2147\/CLEP.S172306"},{"key":"1073_CR15","doi-asserted-by":"publisher","unstructured":"Adelborg K, Corraini P, Darvalics B, Frederiksen H, Ording A, Horv\u00e1th-Puh\u00f3 E, \u2026 S\u00f8rensen HT. Risk of thromboembolic and bleeding outcomes following hematological cancers: a Danish population-based cohort study. J Thromb Haemost: JTH. (2019);17(8):1305\u20131318. https:\/\/doi.org\/10.1111\/jth.14475","DOI":"10.1111\/jth.14475"},{"key":"1073_CR16","doi-asserted-by":"publisher","unstructured":"Sorigue M, Nieto J, Santos-Gomez M, Sarrate E, Jim\u00e9nez M-J, Morales-Indiano C, \u2026 Xicoy B. Indications and use of, and incidence of major bleeding with, antithrombotic agents in myelodysplastic syndrome. Leuk Res. 2018;73:24\u201328. https:\/\/doi.org\/10.1016\/j.leukres.2018.08.017","DOI":"10.1016\/j.leukres.2018.08.017"},{"issue":"5","key":"1073_CR17","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/hae.12445","volume":"20","author":"REG Schutgens","year":"2014","unstructured":"Schutgens REG, Klamroth R, Pabinger I, Malerba M, Dolan G, ADVANCE working group. Atrial fibrillation in patients with haemophilia: a cross-sectional evaluation in Europe. Haemophilia. 2014;20(5):682\u20136. https:\/\/doi.org\/10.1111\/hae.12445.","journal-title":"Haemophilia"},{"key":"1073_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02097-5","author":"M Toselli","year":"2020","unstructured":"Toselli M, Bosi D, Benatti G, Solinas E, Cattabiani MA, Vignali L. Left atrial appendage closure: a balanced management of the thromboembolic risk in patients with hemophilia and atrial fibrillation. J Thromb Thrombolysis. 2020. https:\/\/doi.org\/10.1007\/s11239-020-02097-5.","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"1073_CR19","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1111\/hae.12055","volume":"19","author":"VTF Cheung","year":"2013","unstructured":"Cheung VTF, Hunter RJ, Ginks MR, Schilling RJ, Earley MJ, Bowles L. Management of thromboembolic risk in persons with haemophilia and atrial fibrillation: is left atrial appendage occlusion the answer for those at high risk? Haemophilia. 2013;19(2):e84\u20136. https:\/\/doi.org\/10.1111\/hae.12055.","journal-title":"Haemophilia"},{"key":"1073_CR20","doi-asserted-by":"publisher","unstructured":"G\u00fcray \u00dc, Korkmaz A, G\u00fcrsoy HT, Elalm\u0131\u015f \u00d6U. Percutaneous left atrial appendage closure in a patient with haemophilia and atrial fibrillation: a case report. Eur Heart J Case Rep. 2019; 3(3). https:\/\/doi.org\/10.1093\/ehjcr\/ytz124","DOI":"10.1093\/ehjcr\/ytz124"},{"issue":"5","key":"1073_CR21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.hrcr.2019.01.014","volume":"5","author":"Z Bhatti","year":"2019","unstructured":"Bhatti Z, Goldbarg S. Combined left atrial appendage closure and ablation in a patient with hemophilia B, paroxysmal atrial fibrillation, and transient ischemic attack. HeartRhythm Case Reports. 2019;5(5):266\u20138. https:\/\/doi.org\/10.1016\/j.hrcr.2019.01.014.","journal-title":"HeartRhythm Case Reports"},{"key":"1073_CR22","doi-asserted-by":"publisher","unstructured":"Ancedy Y, Berthelot E, Lang S, Ederhy S, Boyer-Chatenet L, Di Angelantonio E, \u2026 Cohen A. Is von Willebrand factor associated with stroke and death at mid-term in patients with non-valvular atrial fibrillation? Arch Cardiovasc Dis. 2018;111(5):357\u2013369. https:\/\/doi.org\/10.1016\/j.acvd.2017.08.004","DOI":"10.1016\/j.acvd.2017.08.004"},{"issue":"4","key":"1073_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/ejh.13296","volume":"103","author":"G Castaman","year":"2019","unstructured":"Castaman G, Giacomelli SH, Biasoli C, Contino L, Radossi P. Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders. Eur J Haematol. 2019;103(4):379\u201384. https:\/\/doi.org\/10.1111\/ejh.13296.","journal-title":"Eur J Haematol"},{"issue":"4","key":"1073_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1053\/spen.2000.20075","volume":"7","author":"AK Chan","year":"2000","unstructured":"Chan AK, deVeber G. Prothrombotic disorders and ischemic stroke in children. Seminars in Pediatric Neurology. 2000;7(4):301\u20138. https:\/\/doi.org\/10.1053\/spen.2000.20075.","journal-title":"Seminars in Pediatric Neurology"},{"key":"1073_CR25","doi-asserted-by":"publisher","unstructured":"Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, \u2026 Vesely SK. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23): 3829\u20133866. https:\/\/doi.org\/10.1182\/bloodadvances.2019000966","DOI":"10.1182\/bloodadvances.2019000966"},{"key":"1073_CR26","doi-asserted-by":"publisher","unstructured":"Malcovati L, Hellstr\u00f6m-Lindberg E, Bowen D, Ad\u00e8s L, Cermak J, Del Ca\u00f1izo C, \u2026 European Leukemia Net. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood. 2013;122(17): 2943\u20132964. https:\/\/doi.org\/10.1182\/blood-2013-03-492884","DOI":"10.1182\/blood-2013-03-492884"},{"key":"1073_CR27","doi-asserted-by":"publisher","unstructured":"Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL, \u2026 Yawn BP. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14(2): 171\u2013232. https:\/\/doi.org\/10.1111\/j.1365-2516.2007.01643.x","DOI":"10.1111\/j.1365-2516.2007.01643.x"},{"key":"1073_CR28","doi-asserted-by":"publisher","unstructured":"Srivastava A, Brewer AK, Mauser\u2010Bunschoten EP, Key NS, Kitchen S, Llinas A, \u2026 Street A. Guidelines for the management of hemophilia. Haemophilia. 2013;19(1):e1\u2013e47. https:\/\/doi.org\/10.1111\/j.1365-2516.2012.02909.x","DOI":"10.1111\/j.1365-2516.2012.02909.x"},{"issue":"6","key":"1073_CR29","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/jth.12916","volume":"13","author":"A Casini","year":"2015","unstructured":"Casini A, Neerman-Arbez M, Ari\u00ebns RA, de Moerloose P. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management. Journal of thrombosis and haemostasis: JTH. 2015;13(6):909\u201319. https:\/\/doi.org\/10.1111\/jth.12916.","journal-title":"Journal of thrombosis and haemostasis: JTH"},{"key":"1073_CR30","doi-asserted-by":"publisher","unstructured":"Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJB, Culebras A, \u2026 Council on Nutrition, Physical Activity and Metabolism. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2013; 44(7): 2064\u20132089. https:\/\/doi.org\/10.1161\/STR.0b013e318296aeca","DOI":"10.1161\/STR.0b013e318296aeca"},{"issue":"4","key":"1073_CR31","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692\u20134. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01204.x.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"1073_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","volume":"8","author":"S Schulman","year":"2010","unstructured":"Schulman S, Anger\u00e5s U, Bergqvist D, Eriksson B, Lassen MR, Fisher W, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost: JTH. 2010;8(1):202\u20134. https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03678.x.","journal-title":"J Thromb Haemost: JTH"},{"key":"1073_CR33","doi-asserted-by":"publisher","unstructured":"Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, \u2026 Tobian AAR. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162(3): 205. https:\/\/doi.org\/10.7326\/M14-1589","DOI":"10.7326\/M14-1589"},{"issue":"10","key":"1073_CR34","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1056\/NEJMcp1810479","volume":"381","author":"N Cooper","year":"2019","unstructured":"Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2019;381(10):945\u201355. https:\/\/doi.org\/10.1056\/NEJMcp1810479.","journal-title":"N Engl J Med"},{"key":"1073_CR35","doi-asserted-by":"publisher","unstructured":"Tzikas A, Holmes DR, Gafoor S, Ruiz CE, Blomstr\u00f6m-Lundqvist C, Diener H-C, \u2026 Lewalter T. Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies. Europace. 2017;19(1); 4\u201315. https:\/\/doi.org\/10.1093\/europace\/euw141","DOI":"10.1093\/europace\/euw141"},{"key":"1073_CR36","doi-asserted-by":"publisher","unstructured":"Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, \u2026 PROTECT AF Steering Committee and Investigators.Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014;312(19):1988\u20131998. https:\/\/doi.org\/10.1001\/jama.2014.15192","DOI":"10.1001\/jama.2014.15192"},{"key":"1073_CR37","doi-asserted-by":"publisher","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, \u2026 White H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23): 2736\u20132747. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.009449","DOI":"10.1161\/CIRCULATIONAHA.110.009449"},{"issue":"10","key":"1073_CR38","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.leukres.2005.03.004","volume":"29","author":"EN Oliva","year":"2005","unstructured":"Oliva EN, Dimitrov BD, Benedetto F, D\u2019Angelo A, Nobile F. Hemoglobin level threshold for cardiac remodeling and quality of life in myelodysplastic syndrome. Leuk Res. 2005;29(10):1217\u20139. https:\/\/doi.org\/10.1016\/j.leukres.2005.03.004.","journal-title":"Leuk Res"},{"key":"1073_CR39","doi-asserted-by":"crossref","unstructured":"Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, \u2026 Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89(6): 2079\u20132088.","DOI":"10.1182\/blood.V89.6.2079"},{"issue":"4","key":"1073_CR40","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1055\/s-0039-1698756","volume":"3","author":"PR van der Valk","year":"2019","unstructured":"van der Valk PR, Mauser-Bunschoten EP, van der Heijden JF, Schutgens REG. Catheter ablation for atrial fibrillation in patients with hemophilia or von Willebrand disease. TH Open. 2019;3(4):e335\u20139. https:\/\/doi.org\/10.1055\/s-0039-1698756.","journal-title":"TH Open"},{"key":"1073_CR41","doi-asserted-by":"publisher","unstructured":"Rod\u00e9s-Cabau J, O\u2019Hara G, Paradis J-M, Bernier M, Rodriguez-Gabella T, Regueiro A, \u2026 Champagne J. Changes in coagulation and platelet activation markers following transcatheter left atrial appendage closure. Am J Cardiol. 2017;120(1):87\u201391. https:\/\/doi.org\/10.1016\/j.amjcard.2017.03.253","DOI":"10.1016\/j.amjcard.2017.03.253"},{"key":"1073_CR42","doi-asserted-by":"publisher","unstructured":"Sherwood M, Bliden KP, Ilkhanoff L, Venkataraman G, Strickberger A, Yazdani S, \u2026 Gurbel PA. Detailed thrombogenicity phenotyping and 1 year outcomes in patients undergoing WATCHMAN implantation: (TARGET-WATCHMAN) a case\u2013control study. J Thromb Thrombolysis. 2020;50(3): 484\u2013498. https:\/\/doi.org\/10.1007\/s11239-020-02205-5","DOI":"10.1007\/s11239-020-02205-5"},{"key":"1073_CR43","doi-asserted-by":"publisher","unstructured":"Dukkipati Srinivas R, Kar Saibal, Holmes David R, Doshi Shephal K, Swarup Vijendra, Gibson Douglas N, \u2026 Reddy Vivek Y. Device-related thrombus after left atrial appendage closure. Circulation. 2018;138(9): 874\u2013885. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035090","DOI":"10.1161\/CIRCULATIONAHA.118.035090"},{"key":"1073_CR44","doi-asserted-by":"publisher","unstructured":"Fauchier L, Cinaud A, Brigadeau F, Lepillier A, Pierre B, Gras D, \u2026 Defaye P. Left atrial appendage closure in atrial fibrillation. J Am Coll Cardiol. 2018;72(22), 2806\u20132807. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.2196","DOI":"10.1016\/j.jacc.2018.08.2196"},{"key":"1073_CR45","doi-asserted-by":"publisher","unstructured":"Asmarats L, O\u2019Hara G, Champagne J, Paradis J-M, Bernier M, O\u2019Connor K, \u2026 Rod\u00e9s-Cabau J. Short-term oral anticoagulation versus antiplatelet therapy following transcatheter left atrial appendage closure. Circulation. Cardiovascular Interventions. 2020;13(8):e009039. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.120.009039","DOI":"10.1161\/CIRCINTERVENTIONS.120.009039"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-021-01073-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-021-01073-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-021-01073-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T04:13:12Z","timestamp":1661227992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-021-01073-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1073"],"URL":"https:\/\/doi.org\/10.1007\/s10840-021-01073-0","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"type":"print","value":"1383-875X"},{"type":"electronic","value":"1572-8595"}],"subject":[],"published":{"date-parts":[[2021,11,25]]},"assertion":[{"value":"5 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethics committee approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All of the patients expressed a consent to participate and for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}